12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 404 Not Found [1] => Date: Fri, 16 Oct 2026 20:29:31 GMT [2] => Content-Type: text/html; charset=iso-8859-1 [3] => Connection: close [4] => x-frame-options: SAMEORIGIN [5] => x-content-type-options: nosniff [6] => x-xss-protection: 1; mode=block [7] => referrer-policy: strict-origin-when-cross-origin [8] => permissions-policy: geolocation=(), microphone=(), camera=() [9] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [10] => Server: cloudflare [11] => strict-transport-security: max-age=31536000; includeSubDomains; preload [12] => cf-cache-status: DYNAMIC [13] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [14] => Speculation-Rules: "/cdn-cgi/speculation" [15] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [16] => Server-Timing: cfEdge;dur=11,cfOrigin;dur=8 [17] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=gG2Hnb%2BMJasIGmh4fc3pvPr2GUBU4LTVW9u7Oxgb3vi40%2FVINt3wX5s8u2iBy1wFTMnBimoydzyVpVo77aTBbwKzzRwTIjMzQMg1nmbLyUL6K%2B0f9sy6cFeetnSOUDSEFeg%3D"}]} [18] => CF-RAY: a4b9d0f28f56f91a-SIN [19] => alt-svc: h3=":443"; ma=86400 ) 789

（吉隆坡13日讯）卫生部不曾通过药物管理局（PBKD）批准任何宣称能治疗和预防骨痛热症、寨卡和基孔肯雅症的草药产品。

卫生总监拿督诺希山医生说，卫生部接获投诉有关该草药产品通过社交媒体刊登广告，声称能治疗和预防骨痛热症。

他今天发文告说，所有向药物管理局注册的产品，其广告必须获得药物广告局的批准，才能向公众传播。

“未经药物广告局批准刊登广告，可在1956年药物（广告及销售）法令下被采取法律行动。一旦罪成，有关人士或公司可被罚款不超过3000令吉或坐牢不超过1年，或两者兼施。”

卫生部劝请民众采取骨痛热症预防措施，同时若出现骨痛热症症状如发烧、头痛、关节疼痛、红疹、想吐、呕吐，或早期状况如持续呕吐、腹痛或疲累，就须尽速求医。

民众可将可疑的药物产品资料提供给国家药剂监管局（NRPA）https://www.npra.gov.my/index.php/public-enquiry-complaints/contactus或致电03-7883 5400，或发送电邮至npra@npra.gov.my。